SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII)
NTII 0.00010000.0%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Apache Indian who wrote (449)2/18/1999 9:25:00 PM
From: Dr. John M. de Castro  Read Replies (1) of 1494
 
What a great letter. Thanks for sharing it. Paul Freiman is a straight shooter. He doesn't make hollow statements. So, I believe that the contents of this letter are 100% accurate. I am particularly struck by the statement

"Merz and NTI are negotiating a major global marketing agreement with a large pharmaceutical company"

What strikes me is the use of the singular. NTI was negotiating with at least 6 different companies. The use of the singular tells me that the negotiations are very far along. I wasn't aware that thing have advanced this far. This is great news. Merz is a very conservative secretive company that I am sure have made the negotiations slow and detailed. The fact that Paul Freiman is talking about a few months to sign the deal is very important.

We shareholders should be very grateful to Freiman that he has kept this company afloat in a very difficult period without entering into some kind of off-shore mega dilution deal or a dreaded floorless convertible. The float is still very small. As such, the value of our shares has been protected. Once, a deal is penned, with the miniscule float, IMHO NTI will soar.

John de C
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext